Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Health Catalyst (HCAT) Revenue (2018 - 2025)

Health Catalyst's Revenue history spans 8 years, with the latest figure at $74.7 million for Q4 2025.

  • For Q4 2025, Revenue fell 6.19% year-over-year to $74.7 million; the TTM value through Dec 2025 reached $311.1 million, up 1.48%, while the annual FY2025 figure was $311.1 million, 1.48% up from the prior year.
  • Revenue reached $74.7 million in Q4 2025 per HCAT's latest filing, down from $76.3 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $80.7 million in Q2 2025 to a low of $55.8 million in Q1 2021.
  • Average Revenue over 5 years is $71.6 million, with a median of $73.8 million recorded in 2023.
  • Peak YoY movement for Revenue: surged 37.84% in 2021, then decreased 6.19% in 2025.
  • A 5-year view of Revenue shows it stood at $64.7 million in 2021, then grew by 6.87% to $69.2 million in 2022, then grew by 8.56% to $75.1 million in 2023, then rose by 6.02% to $79.6 million in 2024, then decreased by 6.19% to $74.7 million in 2025.
  • Per Business Quant, the three most recent readings for HCAT's Revenue are $74.7 million (Q4 2025), $76.3 million (Q3 2025), and $80.7 million (Q2 2025).